Tweeter button Delicious button Digg button Stumbleupon button
Liver Cancer | Sirtex Medical Inc. Reports 23.7 Percent Dose Sales Growth Of SIR-Spheres Microspheres In Second Quarter

WOBURN, Mass.–(BUSINESS WIRE)–

Sirtex Medical Inc. , a subsidiary of Sirtex Medical Limited ( SRX.AX ), a leading manufacturer of targeted, innovative liver cancer therapies, recently announced that second quarter dose sales of SIR-Spheres microspheres grew 23.7 percent in the Americas region compared to the previous corresponding period for the quarter ending December 31, 2013.

“The Americas team continues to execute our strategic plan to expand the use of SIR-Spheres microspheres in both North and South America and as a result experienced outstanding dose sales growth in the second quarter,” said Mike Mangano, president of Sirtex Medical Inc. “During the remainder of this fiscal year we will focus our efforts on educating physician communities about the latest data that continues to demonstrate the therapy’s safety and efficacy. We look forward to the results of the landmark SIRFLOX study, which completed enrollment in April 2013 and is intended to further illustrate SIR-Spheres microspheres’ role as an earlier standard of care for metastatic colorectal cancer patients.”



liver cancer

Natural Cancer Treatments.

Over 350 Treatments and 2,000 Testimonials That No-one Else Will Tell You About.

Alternative cancer treatment could save your life .. How over 2,000 people have successfully used the alternative cancer treatments.

Discover over 350 gentle and non-toxic cancer treatments.

Read More: Visit Publisher Site

Dose sales in all regions rose a combined 18.7 percent during the period. Europe, Middle East and Africa (EMEA) achieved dose sales growth of 5.9 percent and Asia Pacific grew 18.2 percent.

Full mid-year financial results will be released later in the quarter.

For more information visit www.Sirtex.com or find the latest updates on the SIR-Spheres microspheres Facebook page ( www.Facebook.com/SIRSpheresmicrospheres ).

About Selective Internal Radiation Therapy using SIR-Spheres microspheres

Selective Internal Radiation Therapy (SIRT), also known as radioembolization, is a proven


Click here to view rest of article from original site


Facebook Twitter Email

Important Disclaimer: Article Comments provided are for general information purposes only and are not intended to substitute for informed professional medical, psychological, tax, accounting, legal, investment, or any other professional advice. We expressly disclaim liability for any product, manufacturer, distributor, service or service provider mentioned or any opinion expressed in these comments or anywhere else within the site. Lastly, we do not endorse any article or comment. Use at your own risk.